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Promoter-speciﬁc transcriptional activators (activators) stimulate tran-
scription through direct interactions with one or more components of
the transcriptionmachinery, termed the “target.” The identiﬁcation of
direct in vivo targetsof activators hasbeenamajor challenge. Previous
studies have provided evidence that the Tra1 subunit of the yeast
SAGA (Spt-Ada-Gcn5-acetyltransferase) complex is the target of the
yeast activator Gal4. However, several other general transcription fac-
tors, in particular the mediator complex, have also been implicated as
Gal4 targets. Here we perform a large-scale genetic screen to derive
and characterize tra1 alleles that are selectively defective for interac-
tion with Gal4 in vivo [Gal4 interaction defective (GID) mutants]. In
contrast toWT Tra1, Tra1 GIDmutants are not recruited byGal4 to the
promoterandcannot supportGal4-directed transcription,demonstrat-
ing the essentiality of the Gal4–Tra1 interaction. In yeast strains
expressing a Tra1 GID mutant, binding of Gal4 to the promoter is un-
expectedly also diminished, indicating that Gal4 and Tra1 bind coop-
eratively. Consistent with cooperative binding, we demonstrate that
the Gal4–Tra1 interaction occurs predominantly on the promoter and
not off DNA. Finally, we show that although Tra1 is targeted by other
activators, these interactions are unaffected byGIDmutations, reveal-
ing an unanticipated speciﬁcity of the Gal4–Tra1 interaction.
bimolecular ﬂuorescence complementation | acidic activation domain |
protein–protein interaction
Transcription initiation by RNA polymerase II involves theassembly of general transcription factors on the core pro-
moter to form a preinitiation complex (PIC). Promoter-speciﬁc
activator proteins (activators) work, at least in part, by increasing
PIC formation (1–4). Activators are modular proteins that con-
tain a DNA-binding domain (DBD) and an activation domain
(AD). Activator-mediated stimulation of PIC assembly is be-
lieved to result from a direct interaction between the AD and
one or more components of the transcription machinery, termed
the “target.” The unambiguous identiﬁcation of the direct in vivo
targets of activators has been a major challenge in the ﬁeld.
Transcriptional induction of yeast genes involved in galactose
utilization (GAL genes) has been a model experimental system for
studying transcriptional activation mechanisms. The well-charac-
terized acidic activator Gal4 is responsible for the transcriptional
stimulation of GAL genes, such as GAL1, which contain Gal4-
binding sites in their promoters (5–7). In the absence of galactose,
the negative regulator Gal80 binds to the Gal4 AD and inhibits its
activity (5, 6). Galactose triggers an association between Gal80
and Gal3, relieving Gal80-mediated inhibition of Gal4.
We have been studying the yeast histone acetyltransferase
(HAT) Spt-Ada-Gcn5-acetyltransferase (SAGA) complex and its
potential role as an activator target (8–10). SAGA regulates the
transcription of ≈10% of yeast genes, including GAL genes (11).
Previous studies from our laboratory and others have provided
evidence that the Tra1 subunit of SAGA is a target of Gal4. Tra1
has also been proposed as a target of several other activators, in
particular Gcn4, which like Gal4 has an acidic AD (12–15).
A number of factors in addition to Tra1 have also been impli-
cated as Gal4 AD targets, including TATA-box binding protein
(TBP) (16, 17), TFIIB (16), the Swi/Snf complex (18), TBP-asso-
ciated factors (19) and, in particular, one or more components of
the mediator complex (19–23). In general, mutations in the Gal4
AD compromise the interaction with all of these proposed targets,
confounding the question of which interaction(s) is essential for
transcriptional activation in vivo. Here we derive Tra1 mutants
that are selectively defective for interaction with Gal4 and use
them to study how Gal4 stimulates transcription in vivo and the
basis by which Tra1 is recognized by Gal4 and other activators.
Results
Isolation of tra1 Mutants That Cannot Support Growth on Galactose.
The strategy we used to derive Tra1 mutants that fail to interact
with the Gal4 AD is summarized in Fig. S1A and described below.
We generated a library of random tra1 mutants by in vitro hy-
droxylamine mutagenesis of a low-copy plasmid expressing TRA1.
The library was transformed into a haploid yeast tra1-Δ strain that
was complemented by WT TRA1 expressed on a low-copy URA3-
containing plasmid. After eviction of the WT TRA1 plasmid on
media containing 5-ﬂuoroorotic acid (5-FOA), strains harboring
the tra1 mutants were analyzed for growth on media containing
glucose (YPD) but not galactose (YPG). This approach yielded 13
tra1mutants that were unable to support growth onYPG (Fig. 1A).
Sequence analysis revealed that the 13 tra1 mutants repre-
sented eight distinct alleles (Fig. S1B). Mutants 2–7 were found
to contain the same mutations, and therefore, of these mutants
only tra1-mut2 was further analyzed. Immunoblot analysis
showed that all of the Tra1 mutants were expressed at levels
comparable to that of WT Tra1 (Fig. S1C).
To conﬁrm that the tra1 mutants selectively abolished GAL
gene expression, we monitored expression of two GAL genes,
GAL1 and GAL3, by quantitative RT-PCR (qRT-PCR). In
strains harboring the eight tra1 mutants, transcription of GAL1
and GAL3 in galactose-containing media was severely compro-
mised relative to that observed in a WT TRA1 strain (Fig. 1B). By
contrast, expression of RPS5 and RPS0B, which are SAGA-in-
dependent genes, were unaffected by the tra1mutants (Fig. S1D).
Development of a Bimolecular Fluorescence Complementation Assay
for Detecting Interactions Between Activators and Tra1 in Vivo. To
detect direct interactions between the mutant Tra1 proteins and
Gal4 in vivo, we developed a bimolecular ﬂuorescence comple-
mentation (BiFC) assay, which has been used for the in vivo
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detection of a wide variety of protein–protein interactions (24,
25). The BiFC assay is based on the formation of a ﬂuorescent
complex comprising two fragments of YFP, which are brought
together by association of two interacting proteins fused to the
fragments (reviewed in ref. 26).
To verify the feasibility of this approach we ﬁrst performed
a series of control experiments that monitored the interaction
between Tra1 and two SAGA-dependent activators, Gal4 and
Gcn4. The experimental strategy for detecting activator–Tra1
interactions using the BiFC assay is shown in Fig. 2A. We derived
a pair of haploid yeast strains, one in which the endogenous Tra1
protein was tagged at the C terminus with theN-terminal fragment
of a YFP variant known as Venus (27) (Tra1-VN), and a second
strain of opposite mating type in which the endogenous activator
was tagged at its C terminus with the C-terminal Venus fragment
(Gal4-VC or Gcn4-VC). Tra1-VN was fully functional, as evi-
denced by its ability to substitute for WT Tra1 in a complementa-
tion assay (Fig. S2). The two haploid strains were then mated, and
the resulting diploid cells were analyzed by ﬂuorescence micros-
copy for a nuclear BiFC signal.
As described above, because of Gal80-mediated inhibition, the
Gal4–Tra1 interaction is expected to occur in the presence but not
the absence of galactose. Fig. 2B (Upper) shows that a BiFC signal
was detected in cells expressing Tra1-VN and Gal4-VC and grown
in YPG but not YPD. Identical results were obtained when the
Venus fragment was fused to Tra1 at its N terminus (VN-Tra1)
(Fig. 2B, Lower). Thus, the BiFC assay detected the Gal4−Tra1
interaction, which, as expected, was galactose dependent.
A Gcn4–Tra1 interaction is expected to occur only under
conditions of amino acid starvation. Fig. 2C shows that a nu-
clear BiFC signal was not detected in cells expressing Tra1-VN
and Gcn4-VC grown in nutrient-rich media (YPD) but was
readily detected in amino acid-starved cells grown on histidine
(His)-lacking medium in the presence of the competitive in-
hibitor 3-aminotriazole (3-AT). Collectively, the results of Fig. 2
demonstrate that the BiFC assay can be used to detect inter-
actions between activators and Tra1.
Identiﬁcation of Tra1 Mutants That Are Unable to Interact with Gal4.
We used the BiFC assay to analyze the interaction between Gal4
and the Tra1 mutants. In these and subsequent BiFC experiments
described below, the endogenous activator was tagged at the C
terminus with VC in a haploid tra1-Δ strain that was com-
plemented by WT TRA1 expressed on a URA3-containing plas-
mid. The strain was then transformed with a low-copy plasmid
expressing a Tra1 mutant protein fused to VN at either the C
terminus (Tra1-mut1, -mut2, -mut8, -mut9, -mut12, and -mut13)
or N terminus (Tra1-mut10 and -mut11), and the BiFC signal was
monitored after eviction of theWTTRA1 plasmid. As expected, in
cells expressing WT Tra1-VN, a nuclear BiFC signal could be
detected upon growth on galactose (Fig. 3A). By contrast, a BiFC
signal was not detected in cells expressing any of the Tra1mutants.
We have previously proposed that Tra1 must be incorporated
into an intact SAGA complex for interaction with Gal4 in vivo
(10). Therefore, one explanation for the inability of the Tra1
mutants to interact with Gal4 is a failure to be incorporated into
SAGA. To address this issue, we analyzed the stable association
between Tra1 mutants and the SAGA subunit Spt20 in a coim-
munoprecipitation assay. Fig. 3B shows that Tra1-mut1 and Tra1-
mut8 coimmunoprecipitated with Spt20 at levels comparable to
that of WT Tra1. Similar results were obtained with two other
SAGA subunits, Spt3 and Spt7 (Fig. S3A). By contrast, the other
mutants were completely (Tra1-mut2, -mut9, -mut10, -mut12, and
-mut13) or partially (Tra1-mut11) defective for interaction with
Spt20. Tra1 is also a subunit of another HAT complex known as
NuA4 (28). Fig. S3B shows that all Tra1 mutants coimmunopre-
cipitated with the NuA4 subunit Eaf1 at WT or, in one instance
(Tra1-mut2), modestly reduced levels, indicating that they were
all incorporated into the NuA4 complex. Collectively, these
results indicate that Tra1-mut1 and Tra1-mut8 are incorporated
into the SAGA complex but are unable to interact with Gal4 and
thus can be classiﬁed as Gal4 interaction defective (GID)
mutants. Tra1-mut8 is of particular importance because it con-
tains only a single amino acid substitution at position 400
(H400Y) (Fig. S1B). The inability of Tra1-mut1 and Tra1-mut8 to
interact with Gal4 and support transcription of GAL genes
Fig. 1. Isolation of tra1mutants that cannot support growth on galactose. (A)
Growth of tra1 mutants 1–13 on YPD and YPG media supplemented with
antimycin. Growth of WT TRA1 and gal4-Δ strains are shown as controls. Cells
were spotted as 10-fold serial dilutions. (B) qRT-PCR analysis monitoring ex-
pressionofGAL1andGAL3 in strains expressingWTTRA1or tra1mutantgrown
in rafﬁnose or galactose. Expression of each gene was normalized to that ob-
served in the WT TRA1 strain grown in rafﬁnose, which was set to 1. The fold
induction in galactose in theWT TRA1 strain is indicated. Error bars indicate SD.
Fig. 2. Development of a BiFC assay for detecting interactions between
activators and Tra1 in vivo. (A) Schematic diagram depicting the BiFC assay.
Tra1 is tagged at the C terminus with the N-terminal Venus fragment (VN),
and the activator (Act) is tagged at the C terminus with the C-terminal Venus
fragment (VC). (B) BiFC assay monitoring interaction between Tra1 and Gal4
in vivo, as evidenced by intense YFP signal (arrowheads) in YPG. The Tra1–
Gal4 interaction occurs in the nucleus, as evidenced by colocalization
(arrowheads) with the DNA stain DAPI. Tra1 was tagged at either the C
terminus (Upper) or N terminus (Lower). (C) BiFC assay monitoring in-
teraction between Tra1 and Gcn4 in vivo, as evidenced by intense YFP signal
in response to amino acid starvation (−His + 3-AT media).
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conclusively establishes that theGal4–Tra1 interaction is essential
for Gal4-directed transcription activation.
Gal4 and Tra1 Bind Cooperatively to the GAL1 Promoter. The in-
teraction between Gal4 and Tra1 is expected to result in re-
cruitment of the SAGA complex to the promoters ofGAL genes.
Therefore, in a yeast strain expressing a Tra1 GID mutant, the
SAGA complex should not be recruited to GAL genes. To
conﬁrm this prediction we performed a series of ChIP assays. As
expected, in galactose association of Tra1-mut1 and Tra1-mut8
with the GAL1 promoter was substantially reduced relative to
WT Tra1 (Fig. 4A). Likewise, association of Spt20 with the
GAL1 promoter was comparably reduced in the two Tra1 GID
mutant strains. By contrast, recruitment of Tra1-mut1 and Tra1-
mut8 to the promoter of RPS0B, a NuA4-dependent gene, was
comparable to that of WT Tra1.
Fig. 4A also shows that in rafﬁnose Gal4 binding was roughly
equivalent in the WT Tra1 and Tra1 GID mutant strains. Un-
expectedly, in galactose binding of Gal4 to the GAL1 promoter
was substantially reduced in the Tra1 GID mutant strains, even
though Gal4 levels were equivalent to that observed in the WT
Tra1 strain (Fig. S4A). Similar results were observed at theGAL7
promoter (Fig. S4B). Binding of Gal4 to the GAL1 promoter was
also reduced in an spt20-Δ strain (Fig. 4B), which does not support
theGal4–Tra1 interaction (10). Collectively, the results in Fig. 4A
and B indicate that as a result of the Gal4–Tra1 interaction, Gal4
and Tra1/SAGA bind cooperatively to the promoter.
Gal4–Tra1 Interaction Occurs Predominantly on the Promoter and Not
off DNA. An important, unresolved question is whether in vivo the
interaction between an activator and its target occurs pre-
dominantly on the promoter or whether the activator–target in-
teraction is sufﬁciently stable that it occurs offDNA.To address this
issue, we used the BiFC assay to monitor the interaction between
Tra1 and a LexA-Gal4 AD fusion-protein that can bind to DNA
only in yeast strains engineered to contain LexA-binding sites. A
summary of the experimental design is shown in Fig. 4C and dis-
cussed below.We ﬁrst constructed a haploid tra1-Δ strain harboring
plasmids expressing Tra1-VN and a LexA DBD-Gal4 AD fusion-
protein tagged with the C-terminal Venus fragment [LexA(DBD)-
Gal4(AD)-VC]. This strain was transformed with a series of con-
structs to derive three strains, the ﬁrst of which (strain 1) expressed
a high-copy plasmid containing four LexA-binding sites located
upstream of aGAL1-lacZ reporter gene (29). Strain 2 was identical
to strain 1 except that the construct lacked upstream LexA-binding
sites (29). In strain 3 the GAL1 core promoter sequence, which is
the site at which SAGA and other PIC components are recruited,
was deleted from the GAL1-lacZ reporter gene. Immunoblot
analysis conﬁrmed that the LexA(DBD)-Gal4(AD)-VC fusion-
protein was expressed equivalently in the three strains (Fig. S5).
We analyzed the interaction between the Gal4 AD and Tra1 in
these three strains using the BiFC assay. Fig. 4D shows that
a nuclear BiFC signal was detected in strain 1 but not in strain 2,
indicating a requirement for LexA-binding sites. As expected, in
strain 1 the nuclear BiFC signal was observed only in galactose.
The nuclear BiFC signal was also absent from strain 3, which
lacked the GAL1 core promoter. Collectively, these results in-
dicate that the Gal4 AD–Tra1 interaction occurs predominantly
on DNA and is dependent upon both activator-binding sites and
the core promoter. We note that in a previous study (8) a Gal4–
Tra1 interaction could be detected on a minimal Gal4-binding
site in a ChIP assay, perhaps because the cross-linking agent
formaldehyde enabled “trapping” of the low-afﬁnity, otherwise
transient interaction between Gal4 and Tra1.
As a control, we performed an analogous experiment to mon-
itor the interaction between Gal4 and its negative regulator,
Gal80. Fig. 4E shows that a nuclear BiFC signal was detected in all
three yeast strains, indicating, as expected, that the Gal4–Gal80
interaction is not dependent upon either activator binding sites or
the core promoter. Notably, unlike theGal4–Tra1 interaction, the
Gal4–Gal80 interaction occurred in both rafﬁnose and galactose,
which is in agreement with previous biochemical experiments
showing that in galactose Gal80 remains physically associated
with Gal4 at a second site (30).
Gal4-Interaction Site on Tra1 Is Highly Selective.We next performed
experiments to determine whether the Tra1 GID mutants were
selectively defective for interaction with the Gal4 AD or were
unable to interact with other activators that also targeted Tra1.
Fig. 5A shows that both Tra1 GID mutant strains grew on His-
lacking medium containing 3-AT, indicating that the mutants
could support Gcn4-directed transcription. Furthermore, a nu-
clear BiFC signal could be detected in strains expressing Gcn4-
VC and either WT Tra1 or a Tra1 GID mutant (Fig. 5B). Thus,
unlike Gal4, Gcn4 functionally interacts with Tra1 GID mutants.
To further investigate the selectivity of the Gal4 interaction
site on Tra1, we sought to identify other activators that interact
with Tra1 in the SAGA complex and determine their sensitivity
to the Tra1 GID mutations. Toward this end, we ﬁrst identiﬁed
Tra1-dependent genes by comparing the mRNA population of
a WT TRA1 strain to that of a strain bearing a temperature-
sensitive tra1 allele (tra1-2ts) (31) under nonpermissive con-
ditions. After inactivation of Tra1, ≈3% of yeast genes were
down-regulated greater than twofold (Dataset S1), consistent
with a previous study that analyzed other tra1 alleles (32).
To identify a set of Tra1-dependent genes that were also
SAGA-dependent, we analyzed the 20 genes most affected by
Tra1 inactivation (Table S1) for dependence on Spt20. We ﬁrst
mined a published expression proﬁling study for genes whose
transcription is compromised in an spt20-Δ strain (11) and then
conﬁrmed these in silico results by qRT-PCR. This combined
analysis identiﬁed 11 genes whose transcription was compro-
mised, relative to WT Tra1, by inactivation of Tra1 or loss of
Spt20 (Fig. 6A). In addition, ChIP analysis showed, as expected,
that Tra1 was bound to the promoters of all 11 genes (Fig. S6A).
Fig. 3. Identiﬁcation of Tra1 mutants that are unable to interact with Gal4.
(A) BiFC assay monitoring the interaction between Gal4 and the mutant Tra1
proteins. (B) Coimmunoprecipitation assay. Spt20-HA was immunoprecipi-
tated with an anti-HA antibody, and the immunoprecipitate analyzed for the
presence of Tra1. The levels of Spt20 and Tra1 in the input extract are shown.
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Signiﬁcantly, the two Tra1 GID mutants did not signiﬁcantly af-
fect transcription of any of these 11 Tra1- and SAGA-dependent
genes (Fig. 6A).
Next, we tested the ability of the activators that mediate ex-
pression of the 11 Tra1- and SAGA-dependent genes to interact
with WT Tra1 and the Tra1 GID mutants. To identify activators
involved in regulating expression of the Tra1- and SAGA-de-
pendent genes, we searched published genome-wide ChIP-
microarray (ChIP-chip) studies (33–37). Using this approach,
predicted activators could be identiﬁed for 10 of the 11 Tra1-
and SAGA-dependent genes analyzed above (Table S1).
We selected ﬁve activators for further analysis: Cbf1, Fkh2,
Mcm1, Reb1, and Zap1. Fig. 6B shows that a nuclear BiFC signal
was detected in yeast strains expressing WT Tra1-VN and either
Cbf1-VC, Fkh2-VC, Mcm1-VC, Reb1-VC, or Zap1-VC (see also
Fig. S6B). Thus, as predicted, all ﬁve of these activators directly
interact with Tra1. Notably, a nuclear BiFC signal was also ob-
served with all ﬁve activators in strains expressing either Tra1
GID mutant. Thus, consistent with the transcription results of
Fig. 6A, these activators directly interact with Tra1, but this in-
teraction is insensitive to the GID mutations.
Finally, in an independent approach, we attempted to identify
genes whose transcription was affected by the Tra1 GID mutants
by comparing genome-wide expression proﬁles of yeast strains
harboring either WT TRA1, tra1-mut1, or tra1-mut8 grown in
YPD. Remarkably, we found only two genes (GSC2 and HSP30)
whose expression was affected more than twofold by the tra1-
mut1 mutation and no genes that were affected more than
twofold by the tra1-mut8 mutation (Fig. 6C and Dataset S1).
Moreover, even for GSC2 and HSP30, qRT-PCR did not con-
ﬁrm the difference in expression levels observed by microarray
analysis and instead revealed that expression of these two genes
was comparable in tra1-mut1, tra1-mut8, and the WT TRA1
strains (Fig. S6C). Collectively, these results indicate that re-
markably few, and possibly no other, yeast activators target the
same Tra1 region at which Gal4 interacts.
Discussion
The results presented here deﬁnitively establish Tra1 as an es-
sential in vivo target of Gal4 by showing that Tra1 mutants se-
lectively defective for interaction with Gal4 cannot support Gal4-
directed transcription. It seems most likely that the sites of the
GIDmutations correspond to the region(s) of Tra1 at which Gal4
interacts. However, we cannot rule out the alternative possibility
that the mutations induce a conformational change that affects
Gal4 interaction at a putative distinct site on Tra1. In either case,
Fig. 4. Gal4 and Tra1 bind cooperatively to the GAL1
promoter. (A) ChIP assay monitoring recruitment of
Tra1, Spt20, and Gal4 to the GAL1 and RPS0B pro-
moters in strains expressing WT TRA1, tra1-mut1, or
tra1-mut8 and grown in media containing galactose
or rafﬁnose. Error bars indicate SD. (B) ChIP assay
monitoring recruitment of Gal4 to the GAL1 pro-
moter in a WT SPT20 or spt20-Δ strain. (C) Schematic
diagram of the BiFC-based strategy to detect whether
the Gal4–Tra1 interaction occurs predominantly on or
off DNA. (D) BiFC assay monitoring the interaction
between Tra1-VN and LexA(DBD)-Gal4(AD)-VC in the
three yeast strains grown in galactose or rafﬁnose. (E)
BiFC assay monitoring the interaction between Gal80-
VN and LexA(DBD)-Gal4(AD)-VC in the three yeast
strains grown in galactose or rafﬁnose.
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the Tra1 mutants are defective for interaction with Gal4 and
therefore do not affect our major conclusions. For Tra1 to in-
teract with Gal4 it ﬁrst must be incorporated into an intact SAGA
complex. The amino acids in Tra1 that we ﬁnd compromise as-
sembly into the SAGA complex are consistent with the results of
a recent study analyzing Tra1 functional domains (38). Our results
indicate that Tra1 does not have an intrinsic ability to interact with
the Gal4 AD but rather requires proper presentation within the
SAGA complex. It seems likely that this ﬁnding is relevant to the
selective interaction of Gal4 with SAGA and not the NuA4
complex, which also contains Tra1.
Several experimental observations have led to the suggestion
that an activator will havemultiple, functionally redundant targets.
For example, in vitro protein–protein interaction experiments
have shown that a single activator such as Gal4 (16–23) or Gcn4
(39, 40) can interact with multiple components of the transcription
machinery. Likewise, in artiﬁcial recruitment experiments, a wide
variety of transcription components can stimulate transcription
and thus could potentially function as targets (3). However, in
contrast to this view, we demonstrate that interaction of Gal4 with
a single site on Tra1 is required for Gal4-directed transcription.
The fact that many yeast activators contain acidic ADs, with
apparently similar sequence features, has suggested that activa-
tors have common targets and recognition sites. Surprisingly,
however, we ﬁnd that the Gal4-interaction region on Tra1 is re-
markably speciﬁc. Our collective results suggest that at most very
few, and likely no other, yeast activators functionally interact with
the same region of Tra1 that is recognized by the Gal4 AD.
In this study, we have performed a series of BiFC experiments
whose results show that the interaction between the Gal4 AD
and Tra1 occurs predominantly on the promoter and not off
DNA. These new results explain our previous ﬁnding that a Gal4
mutant lacking its DBD failed to interact with Tra1 in vivo (10).
Our results help explain how cellular activators avoid a tran-
scription inhibitory process referred to as “squelching,” which
occurs after overexpression of a strong AD, such as the herpes
simplex virus VP16 AD (41, 42). Squelching results from the
sequestration of the target by the activator off the promoter;
the target is thus unavailable for promoter-bound activators,
resulting in transcriptional inhibition. By interacting with Tra1
predominantly on the promoter and not off DNA, Gal4 avoids
squelching. Squelching is dependent upon both the strength and
concentration of the overexpressed AD (41, 42). On the basis of
these considerations, we speculate that cellular activator–target
interactions are in general weak, thus ensuring that they occur
only on the promoter where they are stabilized by the many other
protein–protein and protein–DNA interactions in the PIC.
Methods
TRA1Mutagenesis Screen. Plasmid pRS414-pDED1-myc-TRA1 (SI Methods) was
mutagenized by treatment with 1 M hydroxylamine (Sigma), 50 mM sodium
pyrophosphate (pH 7.0), 100 mM NaCl, and 2 mM EDTA at 75 °C for 30 min
(43). The mutagenized library was ampliﬁed in bacteria and transformed
into a haploid tra1-Δ strain LLY154 (Table S2). Cells were plated on −Trp-5-
FOA media, and ≈1,200 5-FOA–resistant colonies were patched and replica
plated onto YPD and YPG media containing 20 μg/mL antimycin A (Sigma).
Colonies able to grow on YPD but not YPG were selected, and the plasmid
was isolated and sequenced. Strains carrying tra1-mut1 and tra1-mut8 were
also analyzed for growth on −His media containing 50 mM 3-AT.
qRT-PCR. Total RNA was extracted (44), and reverse transcription was per-
formed using SuperScript II Reverse Transcriptase (Invitrogen) followed by
qPCR using Fast SYBR Green Master Mix (Applied Biosystems) using the
primers listed in Table S3. For the experiments shown in Fig. 1B and Fig. S1D,
cells were grown in 2% rafﬁnose followed by 2% galactose for 5 min.
Fig. 5. Gcn4 functionally interacts with the Tra1 GID mutants. (A) Growth of
tra1-mut1 and tra1-mut8 on His-lacking media containing or lacking 3-AT.
Growth of WT TRA1 and gcn4-Δ strains are shown as controls. (B) BiFC assay
monitoring the interaction between Tra1-VN and Gcn4-VC in His-lacking
media containing or lacking 3-AT.
Fig. 6. The Gal4-interaction site on Tra1 is highly selective. (A) qRT-PCR
analysis monitoring expression of 11 Tra1- and SAGA-dependent genes in
tra1-ts, spt20-Δ, tra1-mut1, and tra1-mut8 strains. Gene expression is pre-
sented relative to that observed in a WT strain, which was set to 1 (indicated
by the red line). Error bars indicate SD. (B) BiFC analysis monitoring the
ability of WT Tra1, Tra1-mut1, or Tra1-mut8 to interact with various acti-
vators. Only merged images are shown (see also Fig. S6B). (C) Scatter plot
analyses comparing gene expression in a WT TRA1 strain and tra1-mut1
strain (Upper) or tra1-mut8 strain (Lower). The red line represents no change
in gene expression; the blue dotted line represents twofold down-regula-
tion. Gray circles represent all of the genes on the array; black circles rep-
resent genes with a P value <0.05; red circles represent genes with a P value
<0.05 and down-regulated more than twofold.
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BiFC Assay. The BiFC signal in cells was examined by ﬂuorescence microscopy
using a Zeiss AXIO Imager Z2 microscope. A total of 100 cells from at least
seven different ﬁelds were counted; representative examples are shown.
Immunoblotting and Coimmunoprecipitation Assays. For Fig. S1C, whole-cell
extracts were prepared as previously described (45), and blots were
probed with a myc (Santa Cruz) or actin (Abcam) antibody. For Fig. S5,
extracts were prepared from strains grown in galactose or rafﬁnose
medium, and blots were probed with a LexA (Santa Cruz) or actin
(Abcam) antibody. For the coimmunoprecipitation experiments of Fig. 3B
and Fig. S3B, Spt20-HA or Eaf1-HA was immunoprecipitated with an HA
antibody, and blots were probed with an HA (Abcam) or myc (Santa Cruz)
antibody. For the coimmunoprecipitation experiments of Fig. S3A, myc-
Tra1 was immunoprecipitated with a myc antibody (Abcam), and en-
dogenous Spt proteins were detected using an Spt3 (Abcam) or Spt7
(Santa Cruz) antibody.
ChIP. ChIP was performed as described previously (33) using a myc (Abcam),
HA (Abcam), or Gal4 (Abcam) antibody. After reversal of the cross-links, the
DNA was PCR-ampliﬁed using gene-speciﬁc primers (listed in Table S3).
Microarray Analyses. Strains MDC1 and MDC3 were grown at 30 °C and
shifted to 37 °C for 60, 90, and 120 min. Haploid TRA1, tra1-mut1, and tra1-
mut8 strains were generated as described in SI Methods. RNA was extracted
according to standard protocols (44) and hybridized to an Affymetrix YG-S98
array. The tra1-mut1/TRA1 and tra1-mut8/TRA1 experiments were done in
duplicate. Statistical analyses were performed using R (46). The RMA method
(47) in the Affy package from Bioconductor (48) was used to summarize the
probe level data and normalize the dataset to remove across array variation.
The Limma package (49) with randomized block design was used to de-
termine whether a gene’s expression level differs between mutant and WT
regardless of time point. Genes with adjusted P value using the B-H method
(50) <0.05 were considered signiﬁcant. The microarray data from this pub-
lication have been deposited in the National Center for Biotechnology
Information’s Gene Expression Omnibus database (http://www.ncbi.nlm.nih.
gov/geo/) under accession number GSE31391.
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